Table 2.
Polymorphism | Genotype | MetS patients | Controls | P1 | ||
---|---|---|---|---|---|---|
| ||||||
N (%) | Mutated allele frequency | N (%) | Mutated allele frequency | |||
rs846910: G>A | G/G | 35 (83.3%) | 34 (79.1%) | |||
G/A | 7 (16.7%) | 0.08 | 9 (20.9%) | 0.10 | 0.615 | |
A/A | 0 (0%) | 0 (0%) | ||||
Total | 42 | 43 | ||||
P2 | 0.841 | 0.745 | ||||
rs45487298: insA | N/N3 | 26 (63.4%) | 25 (58.1%) | |||
N/insA | 14 (34.1%) | 0.20 | 16 (37.2%) | 0.23 | 0.930 | |
insA/insA | 1 (2.4%) | 2 (4.7%) | ||||
Total | 41 | 43 | ||||
P2 | 0.856 | 0.962 |
significance of χ2 / Fisher’s exact test for comparison of genotype frequencies between MetS patients and controls.
P-value for Hardy-Weinberg equilibrium.
N – wild-type allele of rs45487298: insA.